Home › Funds › Two Sigma Investments › LXEO
Two Sigma Investments position in LXEO
LEXEO THERAPEUTICS INC · Health Care
Latest position (Q1 2026)181.68K sh
Reported value held$1.04M
Portfolio Weight0.00%
First reportedQ1 2025
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 36.62K | $127.08K | New |
| Q1 2025 | 36.62K | $127.08K | New |
| Q2 2025 | 69.24K | $278.35K | Add |
| Q2 2025 | 69.24K | $278.35K | Add |
| Q3 2025 | 84.76K | $562.83K | Add |
| Q4 2025 | 400.57K | $3.98M | Add |
| Q1 2026 | 181.68K | $1.04M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding LXEO
- Vanguard Group 3.89M sh · $38.67M · Q4 2025
- Janus Henderson Group 4.98M sh · $28.51M · Q1 2026
- BlackRock Inc 5.74M sh · $26.72M · Q2 2026
- Citadel Advisors 3.90M sh · $18.15M · Q2 2026
- Millennium Management 2.83M sh · $13.19M · Q2 2026
- Balyasny Asset Management 2.41M sh · $11.23M · Q2 2026
- Goldman Sachs Group 2.15M sh · $10.01M · Q2 2026
- Geode Capital Management 1.75M sh · $8.14M · Q2 2026
- Northern Trust Corp 867.39K sh · $4.04M · Q2 2026
- Bank of America Corp 490.33K sh · $2.28M · Q2 2026
- Morgan Stanley 395.10K sh · $1.84M · Q2 2026
- UBS Group AG 354.04K sh · $1.65M · Q2 2026